Cytosorbents (CTSO) EBT Margin Growth (3y) (2014 - 2026)
Cytosorbents (CTSO) EBT Margin Growth (3y) (2014 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | -429.00 |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | 574.00 |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | 55.00 |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | 764.00 |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | 835.00 |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | 598.00 |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | 125.00 |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | 631.00 |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | 423.00 |
| 10 | Cytosorbents | 19.47 Mn | 15.06 Mn | 7.05 Mn | 2,892.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -16,371.00 |
| Mar 31, 2026 | -4,706.00 |
| Dec 31, 2025 | -3,974.00 |
| Sep 30, 2025 | 11,277.00 |
| Jun 30, 2025 | -13,411.00 |
| Mar 31, 2025 | 8,622.00 |
| Dec 31, 2024 | 12,008.00 |
| Sep 30, 2024 | 3,350.00 |
| Jun 30, 2024 | -967.00 |
| Mar 31, 2024 | -2,841.00 |
| Dec 31, 2023 | -6,507.00 |
| Sep 30, 2023 | -9,632.00 |
| Jun 30, 2023 | -4,080.00 |
| Mar 31, 2023 | -3,784.00 |
| Dec 31, 2022 | 4,806.00 |
| Sep 30, 2022 | -3,745.00 |
| Jun 30, 2022 | -7,114.00 |
| Mar 31, 2022 | -909.00 |
| Dec 31, 2021 | 590.00 |
| Sep 30, 2021 | -1,331.00 |